Publications

​​

1. ​El-Baroudy H, Delgadillo XM, Bamania N, Sivakumar B, Dwivedi S, Chowdhury B, Joseph N, Pathak S, Mitzkus S, Ahmed S, Krishnan A*. Macrophage migration inhibitory factor is a potential therapeutic target for cisplatin-induced peripheral neuropathy in breast cancer (under revision in Neuro-Oncology Advances; Preprint available in bioRxviv: https://www.biorxiv.org/content/10.1101/2025.05.13.653890v1).

​

​2. Price JDW, Vizeacoumar FS, Abuhussein O, Maranda V, Zhang Y, Adachi H, Nguyen K, Kyrylenko L, Rangel-Pozzo A, Dong H, Gong L, Materi A, Walke P, Ganapathysamy A, Denomy C, Freywald T, Dahiya R, Elhasasna H, Saxena A, Vizeacoumar JP, Patel H, Rajamanickam K, de Oliveira DM, Lazell-Wright M, Morales AM, Aggarwal A, Xu JL, Alli N, Munhoz EP, Gao P, Salsman J, Dahiya DK, Kola NS, Gonzalez-Lopez C, Thibault P, Levin M, Dellaire G, Jette N, Groot G, Köbel M, Lee CH, Hopkins L, Krishnan A, Ahmed S, Eskiw C, Barakat KH, Thakur A, Wu Y, DePinho RA, Mai S, Yu YT, Wong JMY, Freywald A, Vizeacoumar FJ. Epigenetic control of telomeric RNA maintains heterochromatin in telomerase-driven cancers. Signal Transduction and Targeted Therapy 2026 Jun 4;11(1):213. (Impact Factor: 81.2)

​

3. Joseph N, Shrestha S, Sassmannshausen I, Mitzkus S, Chumala P, Sivakumar B, Baiju V, Ahmed S, Rees H, Katselis GS, Krishnan A*. Defining the cellular and molecular features of nerve-invaded cancer cells using a newly characterized experimental model. Cell Death Discovery 2025 Jul 8;11(1):314. (Impact Factor: 10.4)

​

4. Sivakumar B, Hammond C, Martinez V, Joseph N, John JV, Kumar A, Krishnan A*. Schwann cells modified to secrete MANF is a potential cellular therapy for peripheral nerve regeneration. Cell Regeneration 2025 Jul 7;14(1):29. (Impact Factor: 5.6)

​

5. Walke P, Price JDW, Vizeacoumar FS, Joseph N, Maranda V, Chowdhury B, Patel J, Zhang Y, Dong H, New L, Ganapathysamy A, Gong LH, Elhasasna H, Bhanumathy KK, Wu Y, Wang Y*, Freywald A*, Krishnan A*, Vizeacoumar F* (*co-corresponding authors). A novel role for Neurog2 in MYCN driven neuroendocrine plasticity of prostate cancer. Oncogene 2025 Apr 29. doi: 10.1038/s41388-025-03413-0. (Impact Factor: 9.1)

 

6. Cunningham CE, Vizeacoumar FS, Zhang Y, Kyrylenko L, Gao P, Maranda V, Dong H, Price JDW, Ganapathysamy A, Hari R, Denomy C, Both S, Wagner K, Wu Y, Khan F, Mosley S, Chen A, Katrii T, Zoller BGE, Rajamanickam K, Walke P, Gong L, Patel H, Lazell-Wright M, Morales AM, Bhanumathy KK, Elhasasna H, Dahiya R, Abuhussein O, Dmitriev A, Freywald T, Munhoz EP, Krishnan A, Ruppin E, Datla JR, Yadav S, Wu Y, Baker K, Empting M, Kiemer AK, Freywald A, Vizeacoumar FJ. Identification of targetable vulnerabilities of PLK-1 overexpressing cancers by synthetic dosage lethality. Cell Genomics 2025 Jun 11; 5(6):100876. (Impact Factor: 8.4)

 

7. Poitras TM, Komirishetty P, Areti A, Larouche M, Krishnan A, Chandrasekhar A, Munchrath E, Zochodne DW. Manipulation of the Myc Interactome to Enhance Nerve Regeneration in a Murine Model. Annals of Neurology 2024 May 31. doi: 10.1002/ana.26950. (Impact Factor: 7.5)

 

8. Krishnan A*, Verge VMK, Zochodne DW (Book Chapter). Hallmarks of peripheral nerve injury and regeneration. Handb Clin Neurol. 2024; 201: 1-17.

 

9. Sivakumar B, Krishnan A*. Mesencephalic astrocyte-derived neurotrophic factor (MANF): An emerging therapeutic target for neurodegenerative disorders. Cells. 2023; 12(7): 1032 (Impact Factor: 6)

 

10. Bautista M, Katselis G, Chowdhury B, Chumala P, Mahendra R, Desai P, Hall J, Kalyaanamoorthy S, Krishnan A*. Comparative proteomics analysis of growth-primed adult dorsal root ganglia reveals key molecular mediators for peripheral nerve regeneration. eNeuro 2023 Jan 5;10 (1):0168-22.2022

 

11. Krishnan A, Areti A, Komirishetty P, Chandrasekhar A, Cheng C, Zochodne DW. Survival of compromised adult sensory neurons involves macrovesicular formation. Cell Death Discovery 2022 Nov 24;8(1):462. (Impact Factor: 10.4)

 

12. Krishnan, A* (Book Chapter). Tumor-Nerve Interface: An Emerging Therapeutic Intervention Point for Solid Cancers. In: Interdisciplinary Cancer Research (2022). Springer, Cham. https://doi.org/10.1007/16833_2022_35

 

13. Krishnan, A* (Book Chapter). Neuroimmune Crosstalk in the Tumor Microenvironment. In: Rezaei, N. (eds) Handbook of Cancer and Immunology (2022). Springer, Cham. https://doi.org/10.1007/978-3-030-80962-1_92-1

 

14. Elhasasna H, Khan R, Bhanumathy KK, Vizeacoumar FS, Walke P, Bautista M, Dahiya DK, Miranda V, Patel H, Balagopal A, Alli N, Krishnan A, Freywald A, Vizeacoumar FJ. (2022). A Drug Repurposing Screen Identifies Fludarabine Phosphate as a Potential Therapeutic Agent for N-MYC Overexpressing Neuroendocrine Prostate Cancers. Cells  2022 Jul 20;11(14):2246. (Impact Factor: 6)

 

15. Bautista, M.,Krishnan, A*. Self-renewal of peripheral nerve resident macrophage: Does it represent a unique activation status? Neural Regeneration Research 2022 May;17(5):999-1000. (Impact Factor: 8.5)

 

16. Dwivedi S, Bautista M, Shrestha S, Elhasasna H, Chaphekar T, Vizeacoumar FS, Krishnan A*. Sympathetic signaling facilitates progression of neuroendocrine prostate cancer. Cell Death Discovery 2021 Nov 22;7(1):364. (Impact Factor: 10.4)

 

17. Asahchop EL, Branton WG, Krishnan A, Chen PA, Yang D, Kong L, Zochodne DW, Brew BJ, Gill MJ, Power C. HIV-associated sensory polyneuropathy and neuronal injury are associated with miRNA-455-3p induction. JCI Insight.2018 Dec 6;3(23). (Impact Factor: 6.8)

 

18. Christie KJ #, Krishnan A #, Martinez JA, Purdy K, Singh B, Eaton S, Zochodne D. Enhancing adult Nerve Regeneration through the knockdown of Retinoblastoma Protein.  Nature Communications 2014 Apr 22; 5:3670 (#equal contribution). (Impact Factor: 18.1)

 

19.Singh B, Singh V#, Krishnan A#, Koshy K, Martinez J, Cheng C, Almiquist C, Zochodne DW. Regeneration of diabetic axons is enhanced by selective knockdown of the PTEN gene. Brain 2014 Apr; 137(Pt 4):1051-67. (#equal contribution)  (Impact Factor: 12.6)